ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1951

Valid and Reliable Physical Function Tests in Idiopathic Inflammatory Myositis

Tanya Chandra1, Raisa Lomanto Silva2, shiri keret3, Akanksha Sharma4, Siamak Moghadam-Kia2, Dana Ascherman5, Chester V. Oddis5 and Rohit Aggarwal5, 1Georgetown University Hospital, Washington, DC, 2University of Pittsburgh Medical Center, Pittsburgh, PA, 3Bnai Zion, Atlit, Israel, 4UPMC Mercy Hospital, Pittsburgh, PA, 5University of Pittsburgh, Pittsburgh, PA

Meeting: ACR Convergence 2023

Keywords: dermatomyositis, Myositis, Patient reported outcomes, physical function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1945–1972) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Idiopathic inflammatory myopathies (IIM) can cause significant impairment in physical function. Sit to Stand (STS) and Timed Up and Go (TUG) are quick and operator-independent measures of physical function. We evaluated the psychometric properties (reliability, validity, and responsiveness) of these compared to established core set measures (CSMs) of disease activity and outcome. We also assessed the feasibility of patients self-performing these tests at home remotely.

Methods: Data from a 6-month prospective observational study on IIM: Myositis Patient Centered Tele-Research Study (My PACER) was analyzed. There were 2 cohorts, a Tele-Research Cohort (TRC; remote enrollment from anywhere in US) and a Center Based Cohort (CBC; in person enrollment from myositis centers). Patient reported assessments and functional assessments (STS and TUG) were collected monthly over 6-months. STS is the number of times a patient can stand from a seated position and sit back down in 30 seconds. TUG is the time needed to rise from a chair, walk 3 meters, return to the chair and sit down. For the CBC, patients were trained in person by the coordinator, whereas for TRC training was provided by pre-recorded video instructions and patients self-performed the tests remotely. These tests were done twice at each visit, with the average of the two used in analysis. In addition, myositis core set measures (CSMs) were assessed by myositis experts at baseline and 6 month follow up (done in person for CBC patients and remotely through telemedicine visits and medical records for TRC patients). We examined test-retest reliability using Spearman correlation. To assess validity, we compared STS and TUG against all CSMs and other disease activity measures at baseline. We assessed responsiveness by assessing differences of median changes in STS and TUG in different categories of improvement according to various outcome measures and compared them using the Mann Whitney Test.

Results: 120 patients (75% female,80.8% Caucasian, mean age of55.5+/- 13.43 years,39.2 % PM, 51.7% DM, 9.1% Necrotizing Myopathy [NM]) participated in the study. There was strong test-retest reliability between baseline and month 1 for STS (r=0.8) and TUG (r=0.87); p< 0.01.Reliability was high regardless of method of recruitment and training for STS, however, TUG showed higher reliability in patients recruited and trained remotely (TRC) as compared to locally (CBC). Reliability was maintained across clinical disease subtypes (DM, PM and NM). At baseline STS and TUG showed very strong correlation with each other (r=-0.75) as well as with all CSMs except Extra-Muscular Global and CK. Strong correlations were seen with Muscle Disease Activity and a validated PRO of physical function (PROMIS-PF 20).At 6 months, STS and TUG were significantly better among patients who improved according to 2016 EULAR/ACR myositis response criteria (Total Improvement Score) compared to those who didn’t.

Conclusion: STS and TUG showed good reliability including when self-performed by patients remotely using video instructions, with excellent construct validity and responsiveness. STS and TUG are feasible functional assessment in myositis that can be performed in clinic or remotely.

Supporting image 1

Table 1. Demographic characteristics of participants

Supporting image 2

Table 2. Spearman Correlation of Sit to Stand (STS) and Timed Up and Go (TUG) with myositis Core Set Measures (CSMs) and other measures at baseline

Supporting image 3

Table 3. Change in Sit to Stand (STS) and Timed Up and Go (TUG) based on response as per 2017 ACR/EULAR Myositis Response Criteria and Patient Assessment of Change


Disclosures: T. Chandra: None; R. Lomanto Silva: None; s. keret: None; A. Sharma: None; S. Moghadam-Kia: None; D. Ascherman: None; C. V. Oddis: Boehringer-Ingelheim, 5, Cabaletta, 5, EMD Serono, 5, Novartis, 5, Pfizer, 1; R. Aggarwal: Actigraph, 2, Alexion, 2, ANI Pharmaceuticals, 2, Argenx, 2, AstraZeneca, 2, Boehringer-Ingelheim, 2, 5, Bristol-Myers Squibb(BMS), 2, 5, CabalettaBio, 2, Capella Bioscience, 2, Corbus, 2, CSL Behring, 2, EMD Serono, 2, 5, Galapagos, 2, Horizon Therapeutics, 2, I-Cell, 2, Janssen, 2, 5, Kezar, 2, Kyverna, 2, Mallinckrodt, 5, Merck, 2, Octapharma, 2, Pfizer, 2, 5, Q32, 5, Roivant, 2, Sanofi, 2, Teva, 2.

To cite this abstract in AMA style:

Chandra T, Lomanto Silva R, keret s, Sharma A, Moghadam-Kia S, Ascherman D, V. Oddis C, Aggarwal R. Valid and Reliable Physical Function Tests in Idiopathic Inflammatory Myositis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/valid-and-reliable-physical-function-tests-in-idiopathic-inflammatory-myositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/valid-and-reliable-physical-function-tests-in-idiopathic-inflammatory-myositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology